medline.ch Respirationstrakt Neoplasie

	Fibroblast activation protein inhibitor-PET/CT in lung cancer: a prospective single-center study with histopathological correlation of fibroblast activation protein expression. Int J Clin Oncol Hiroshima T, Kimura T, Watabe T, Matsui T, Omura A, Sugiura Y, Nagata H, Kimura K, Fukui E, Kanou T, Ose N, Tatsumi M, Giesel FL, Morii E, Shintani Y. PMID: 42228299 [PubMed - as supplied by publisher]
	Prognostic impact of weight loss during first-line chemotherapy in extensive-disease small cell lung cancer. Support Care Cancer Fujisaki T, Naito T, Kumaki S, Kataoka S, Saito S, Matsuda S, Kobayashi H, Ko R, Wakuda K, Ono A, Murakami H, Takahashi T, Kenmotsu H. PMID: 42228208 [PubMed - indexed for MEDLINE]
	Implementing an Evidence-Based Smoking Cessation Referral Tool Kit in a High-Risk Lung Cancer Screening Clinic. Clin J Oncol Nurs Mathey K, Von Ah D. PMID: 42227788 [PubMed - in process]
	Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. Thorac Cancer Murakami S, Hiroshima Y, Katakura S, Kondo T, Kato T, Yokose T, Saito H. PMID: 42227590 [PubMed - in process]
	Unveiling the Mechanisms of Liujunzi Decoction in COVID-19/Lung Cancer Comorbidity: A Network Pharmacology and Molecular Docking Study. Curr Pharm Des Yang P, Li Q, Zuo J, Chu T, Shu X, Shu P. PMID: 42227389 [PubMed - as supplied by publisher]
	Diagnostic pathways for lung cancer patients in Denmark: General practice events, first referral and stage at diagnosis. Acta Oncol Jarbøl DE, Haastrup P, Rasmussen S, Lauridsen GB, Balasubramaniam K, Ahrenfeldt LJ, Lykkegaard J, Sætre LMS. PMID: 42227152 [PubMed - in process]
	Solitary Parotid Metastasis as an Atypical Site of Recurrence in Lung Squamous Cell Carcinoma: A Diagnostic Difficulty. Cureus Prateaux MA, Haouane MA, Rharrassi I, Azami MA. PMID: 42226864 [PubMed]
	Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study. Drug Des Devel Ther Lu BW, Zhao C, Wang DZ, Wang W. PMID: 42226757 [PubMed - in process]
	Welding and brazing fumes and lung cancer risk: a systematic review and meta-analysis. J Occup Med Toxicol Kim Y, Kim EM, Kim I. PMID: 42226199 [PubMed]
	Construction of a nomogram model for postoperative complications following thoracoscopic lung cancer surgery in elderly patients: a study based on an elderly patient population. BMC Geriatr Ma S, Du H, Li F, Bu L, Wang L. PMID: 42226137 [PubMed - as supplied by publisher]
	Mapping the antibody-drug-conjugates landscape in non-small cell lung cancer: Where are we and where are we going? Cancer Parisi C, Barlesi F, Planchard D. PMID: 42226007 [PubMed - in process]
	The future promise of antibody-drug conjugates in extensive-stage small cell lung cancer. Cancer Sethakorn N, Chiang AC. PMID: 42226003 [PubMed - in process]
	SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial. Nat Med Byers LA, Cho BC, Cooper AJ, Chiang AC, Han JY, Furqan M, Dowlati A, Morgensztern D, Papadopoulos KP, Choudhury NJ, Vieito M, Bar J, Kim JH, Akerley W, Kim TM, Kim YC, Paz-Ares L, Ahn MJ, Yokouchi H, Meiman D, Munasinghe W, Ogunyankin O, Jahchan N, Wang S, Ferlini C, Robinson RR, Kohlhapp FJ, Palenski T, Rivell G, Hingorani P, Chandana S. PMID: 42225988 [PubMed - as supplied by publisher]
	Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial. Signal Transduct Target Ther Zhao Q, Li Y, Zhang H, Han D, Kan Y, Sun H, Liu C, Wang L, Han X, Hua Y, Wang X, Fu C, Wang Z, Du X, Liu J, Li B, Huang W. PMID: 42225651 [PubMed - in process]
	Lung cancer risk prediction models and asbestos exposure: a validation study on the Western Australia Asbestos Review Program. Occup Environ Med Kumarasamy C, Betts K, Norman R, Bennett K, Franklin P, Tammemägi M, Brims F. PMID: 42225416 [PubMed - as supplied by publisher]
	Overcoming immunotherapy resistance in extensive-stage small cell lung cancer: insights into mechanisms and therapeutic opportunities. Crit Rev Oncol Hematol Guan R, Zhang C, Zhang J, Du S, Wang H, Zhang Y, Abdi AAM, Wang H. PMID: 42225194 [PubMed - as supplied by publisher]
	Advances in the management of small cell lung cancer: thoracic and cranial radiation therapy and sequencing with systemic therapy. Cancer Treat Res Commun Liefman D, Lehman M. PMID: 42225009 [PubMed - as supplied by publisher]
	The patient experience of pathways to lung cancer diagnosis in primary care: A mixed methods investigation of factors influencing timeliness of diagnosis. Patient Educ Couns Mander K, Yap A, Galpin K, Decaria A, Laidsaar-Powell R, Brown B. PMID: 42224915 [PubMed - as supplied by publisher]
	SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma. Crit Rev Immunol Feng X, Gao L, Xue Y, Zhang Y, Cao H, Wange T. PMID: 42224680 [PubMed - in process]
	Standard Versus Reduced Sotorasib Dosing in KRAS G12C-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis-Have We Answered the Dosing Question? JCO Oncol Pract Aung WY, Neumann M, Wang KY, Chukkalore D, Morales J, Seetharamu N. PMID: 42224643 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 160119

Seite 1 von 8006



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung